GoodRX calculated fill percentages for weight loss medications using a nationally representative sample of prescription fills. Data covered claims filed between Jan. 1 and Oct. 31. The organization also calculated the out-of-pocket cost for a 30-day supply of each medication based on the claims data. Learn more about the methodology here.
Medication fills for Zepbound have increased by more than 300% since the start of the year. The average out-of-pocket cost for patients was $230 per fill — the highest of any medication included in the analysis.
Wegovy fills also increased by more than 100% this year, with the average cost sitting at about $75.
In general, costs were higher for patients taking GLP-1s for weight loss versus diabetes. Patients filling Zepbound prescriptions for weight loss paid on average $141 more than those taking Mounjaro for diabetes, even though both medications have the same active ingredient.
In addition, 18% of patients with commercial insurance had no coverage for at least one brand-name weight loss medication.
View the full analysis here.
Interested in sharing your own thoughts? Take this quick survey about how your system is approaching GLP-1 medications here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
